Catalent is a company within the Pharmaceuticals & Biotechnology category. Catalent, Inc. is a multinational corporation headquartered in Somerset, New Jersey. It is a leading global provider of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. The company serves as a Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry.
Catalent was founded in 2007 and is headquartered in Somerset, NJ.
Catalent is rated Leader on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for Catalent is Moderate. Significant factual deltas detected.
AI models classify Catalent as a Challenger. AI names competitors first.
Catalent appeared in 6 of 8 sampled buyer-intent queries (75%). Catalent dominates high-intent branded queries but loses visibility on broad 'biologics manufacturing' searches to larger conglomerates like Thermo Fisher or Lonza.
AI models reliably identify Catalent as a global leader in drug delivery and CDMO services. However, the narrative is currently shifting from a general service provider to a strategic asset of Novo Holdings, which creates a lag in how its independence is described. Key gap: Some sources may still describe Catalent as a purely independent public company, failing to emphasize the pending acquisition by Novo Holdings which significantly alters its future competitive landscape.
Of 5 key facts verified about Catalent, 4 are well-documented (likely accurate across AI models), 1 have limited sourcing, and 0 are retrieval-dependent and may be inaccurate without live search.
Specific facility-level details or precise employee counts in real-time, as these are subject to recent restructuring and the pending merger.
Buyers turn to Catalent for In-house manufacturing: Pharmaceutical companies managing their own in-house manufacturing, research, and distribution facilities., Specialized Consultancy: Hiring specialized consulting firms to design clinical trials or supply chain logistics without integrated manufacturing., among 2 documented problem areas.
Buyers evaluating Catalent typically ask AI models about "top CDMO companies biologics", "drug delivery technology providers", "generic drug manufacturers USA", and 3 similar queries.
Catalent's main competitors are Lonza Group. According to AI models, these are the brands most frequently named alongside Catalent in buyer-intent queries.
Catalent's core products are Oral, Injectable, and Respiratory delivery technologies; Biologics development; Cell and gene therapy manufacturing; Clinical supply services; Softgel encapsulation..
Catalent uses Enterprise/Custom.
Catalent serves Pharmaceutical companies, Biotechnology firms, Consumer health brands..
Catalent Unrivaled breadth of drug delivery technologies combined with global scale in both small molecule and advanced biologics.
Brand Authority Index (BAI) tier: Leader (exact score locked for unclaimed brands)
Archetype: Challenger
https://optimly.ai/brand/catalent
Last analyzed: April 10, 2026
Founded: 2007 (Spin-off from Cardinal Health)
Headquarters: Somerset, New Jersey, USA